30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Hepion Pharmaceuticals Inc (HEPA)

Track

Over the last 90 days, Hepion Pharmaceuticals Inc. has seen significant insider buying activity, with a net buy value of $400,000. Four insiders, including two executives, made net purchases totaling $300,000. This activity represents 0.86% of the company's float, with executive net buying at 0.65%. No insider selling was reported.
Stock chart
Ticker: HEPA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Purcell Michael J.
1 purchase — total 50,000 USD
Buy 21 Apr 2026
Value US$618,966.98 | Price 132.26 | Shares 16,980
Buy 21 Apr 2026
Value US$262,669.91 | Price 118.64 | Shares 45,083
Buy 21 Apr 2026
Value US$50,000.00 | Price 0.04 | Shares 1,250,000
Buy 21 Apr 2026
Value US$200,000.00 | Price 0.04 | Shares 5,000,000
Buy 21 Apr 2026
Value US$50,000.00 | Price 0.04 | Shares 1,250,000
Buy 27 Nov 2023
Value US$7,625.00 | Price 3.05 | Shares 2,500
Buy 24 Nov 2023
Value US$7,725.00 | Price 3.09 | Shares 2,500
Buy 19 Sep 2023
Value US$5,640.00 | Price 5.64 | Shares 1,000
Buy 18 Sep 2023
Value US$8,960.00 | Price 5.60 | Shares 1,600
Buy 15 Sep 2023
Value US$4,623.57 | Price 5.37 | Shares 861
Buy 15 Sep 2023
Value US$757.55 | Price 5.45 | Shares 139
Buy 15 Sep 2023
Value US$5,820.00 | Price 5.82 | Shares 1,000
Buy 15 Sep 2023
Value US$8,640.00 | Price 5.40 | Shares 1,600
Buy 18 Feb 2021
Value US$40,000.00 | Price 2.00 | Shares 20,000
Buy 18 Feb 2021
Value US$20,000.00 | Price 2.00 | Shares 10,000
Buy 16 Feb 2021
Value US$22,000.00 | Price 2.20 | Shares 10,000
Buy 18 Dec 2020
Value US$38,200.00 | Price 1.91 | Shares 20,000
Buy 8 Dec 2020
Value US$39,417.50 | Price 1.58 | Shares 25,000
Buy 2 Dec 2020
Value US$10,710.00 | Price 1.53 | Shares 7,000
Buy 1 Dec 2020
Value US$19,920.00 | Price 1.66 | Shares 12,000
Buy 25 Nov 2020
Value US$7,290.00 | Price 1.62 | Shares 4,500
Buy 20 Jun 2017
Value US$13,000.00 | Price 0.65 | Shares 20,000
Buy 18 Feb 2016
Value US$10,000.00 | Price 1.00 | Shares 10,000
Buy 30 Nov 2015
Value US$1,075.00 | Price 2.15 | Shares 500
Buy 23 Nov 2015
Value US$4,100.00 | Price 1.64 | Shares 2,500
Buy 4 Mar 2014
Value US$6,545.57 | Price 1.49 | Shares 4,393
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-27 2026-04-21 B Purchase
1.4
Purcell Michael J.
Non-Executive Director
16,980 -14.9%
132.26
US$618,967 		16,980 -14.9% 132.26 US$618,967
2026-04-27 2026-04-21 B Purchase
Stetz Gary S.

Interim CEO

Executive Director
45,083 +12.1%
118.64
US$262,670 		45,083 +12.1% 118.64 US$262,670
2026-04-27 2026-04-21 B Purchase
LoPriore Vincent S

Executive Chairman

Executive Director Large shareholder
55,890 -33.4%
202.90
US$3,766,015 		55,890 -33.4% 202.90 US$3,766,015
2026-04-27 2026-04-21 B Purchase
LoPriore Vincent S

Executive Chairman

Executive Director Large shareholder
5,000,000 +inf%
0.04
US$200,000 		5,000,000 +inf% 0.04 US$200,000
2026-04-27 2026-04-21 B Purchase
4.0
Appajosyula Sireesh
Non-Executive Director
1,250,000 +inf%
0.04
US$50,000 		1,250,000 +inf% 0.04 US$50,000
2023-11-28 2023-11-27 B Purchase
2.4
Wijngaard Peter
Non-Executive Director
2,500 +35.7%
3.05
US$7,625 		2,500 +35.7% 3.05 US$7,625
2023-11-28 2023-11-24 B Purchase
2.4
Wijngaard Peter
Non-Executive Director
2,500 +55.5%
3.09
US$7,725 		2,500 +55.5% 3.09 US$7,725
2023-09-20 2023-09-19 B Purchase
2.4
Wijngaard Peter
Non-Executive Director
1,000 +28.6%
5.64
US$5,640 		1,000 +28.6% 5.64 US$5,640
2023-09-19 2023-09-18 B Purchase
2.9
Foster Robert T

CEO and Director

Executive Director
1,600 +3.3%
5.60
US$8,960 		1,600 +3.3% 5.60 US$8,960
2023-09-20 2023-09-15 B Purchase
2.4
Wijngaard Peter
Non-Executive Director
861 +32.6%
5.37
US$4,624 		861 +32.6% 5.37 US$4,624
2023-09-20 2023-09-15 B Purchase
2.4
Wijngaard Peter
Non-Executive Director
139 +5.6%
5.45
US$758 		139 +5.6% 5.45 US$758
2023-09-20 2023-09-15 B Purchase
2.4
Wijngaard Peter
Non-Executive Director
1,000 +66.6%
5.82
US$5,820 		1,000 +66.6% 5.82 US$5,820
2023-09-18 2023-09-15 B Purchase
2.9
Foster Robert T

CEO,CSO and Director

Executive Director
1,600 +3.4%
5.40
US$8,640 		1,600 +3.4% 5.40 US$8,640
2021-02-18 2021-02-18 B Purchase
2.9
Foster Robert T

CEO and Director

Executive Director
20,000 +79.2%
2.00
US$40,000 		20,000 +79.2% 2.00 US$40,000
2021-02-18 2021-02-18 B Purchase
3.2
Cavan John T

Chief Financial Officer

Officer
10,000 +208.3%
2.00
US$20,000 		10,000 +208.3% 2.00 US$20,000
2021-02-18 2021-02-16 B Purchase
2.4
Wijngaard Peter
Non-Executive Director
10,000 +50.0%
2.20
US$22,000 		10,000 +50.0% 2.20 US$22,000
2020-12-21 2020-12-18 B Purchase
2.4
Wijngaard Peter
Non-Executive Director
20,000 +inf%
1.91
US$38,200 		20,000 +inf% 1.91 US$38,200
2020-12-08 2020-12-08 B Purchase
2.9
Foster Robert T

CEO and Director

Executive Director
25,000 +9652.5%
1.58
US$39,418 		25,000 +9652.5% 1.58 US$39,418
2020-12-02 2020-12-02 B Purchase
3.2
BRANCACCIO JOHN P
Non-Executive Director
7,000 +87500.0%
1.53
US$10,710 		7,000 +87500.0% 1.53 US$10,710
2020-12-01 2020-12-01 B Purchase
3.6
JACOB GARY S
Non-Executive Director
12,000 +20339.0%
1.66
US$19,920 		12,000 +20339.0% 1.66 US$19,920
2020-11-30 2020-11-25 B Purchase
3.2
Cavan John T

Chief Financial Officer

Officer
4,500 +1500.0%
1.62
US$7,290 		4,500 +1500.0% 1.62 US$7,290
2017-06-22 2017-06-20 B Purchase Cavan John T

CFO
20,000 +inf%
0.65
US$13,000 		20,000 +inf% 0.65 US$13,000
2016-02-18 2016-02-18 B Purchase SAPIRSTEIN JAMES

Chief Executive Officer

Executive Director
10,000 +333.3%
1.00
US$10,000 		10,000 +333.3% 1.00 US$10,000
2015-12-01 2015-11-30 B Purchase SAPIRSTEIN JAMES

Chief Executive Officer

Executive Director
500 +20.0%
2.15
US$1,075 		500 +20.0% 2.15 US$1,075
2015-11-24 2015-11-23 B Purchase SAPIRSTEIN JAMES

Chief Executive Officer

Executive Director
2,500 +inf%
1.64
US$4,100 		2,500 +inf% 1.64 US$4,100
2014-03-07 2014-03-04 B Purchase BRANCACCIO JOHN P Non-Executive Director
4,393 +218.0%
1.49
US$6,546 		4,393 +218.0% 1.49 US$6,546
Explore more

More insider trading research around Hepion Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America